Lisa DeFrancesco
SVP, Investor Relations and Corporate Communications
Replay available
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Mike Exton
Chief Executive Officer and Director
Craig Granowitz
Senior Vice President and Chief Medical Officer
Scott Coiante
Senior Vice President and Chief Financial Officer
Yuan Kim
Analyst, Citigroup
Brian Bolton
Analyst, Jefferies
Roana Ruiz
Analyst, B-Rank Partners
Yasmine Rahimi
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Lexicon Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.381 -- 00:00:06.662 Welcome to the Lexicon Pharmaceuticals Second Quarter 2026 Financial Results 00:00:06.662 -- 00:00:12.763 Conference Call. At this time, all participants are in listen-only mode. 00:00:12.763 -- 00:00:18.685 Following management's prepared remarks, we will hold a brief question and answer session. 00:00:18.685 -- 00:00:23.926 As a reminder, this call is being recorded today, August 6, 2026. 00:00:23.926 -- 00:00:28.567 I will now turn the call over to Lisa DeFrancesco, 00:00:28.567 -- 00:00:33.593 SVP, Investor Relations, and Corporate Communications for Lexicon. 00:00:33.593 -- 00:00:36.214 Please go ahead, Lisa. 00:00:36.876 -- 00:00:42.260 Thank you, Therese. Good morning and welcome to our second quarter 2026 earnings call. 00:00:42.260 -- 00:00:47.303 Joining me today are Dr. Mike Exton, Lexicon's Chief Executive Officer and Director, 00:00:47.303 -- 00:00:51.947 Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Coiante, 00:00:51.947 -- 00:00:54.989 Senior Vice President and Chief Financial Officer. 00:00:54.989 -- 00:00:58.812 This morning, Lexicon issued a press release announcing our financial results for the 00:00:58.812 -- 00:01:04.410 second quarter of 2026 which is available on our website at www.lexpharma.com 00:01:04.410 -- 00:01:09.415 and through our SEC filings. A webcast of this call along with a slide presentation is 00:01:09.415 -- 00:01:13.719 also available on our website. During this call, we will review the information provided 00:01:13.719 -- 00:01:17.082 in our release, provide a corporate update, and then use the remainder of our time to 00:01:17.082 -- 00:01:21.626 answer your questions. Before we begin, let me remind you that we will be making forward-looking 00:01:21.626 -...